LB Pharmaceuticals, Inc. (LBRX)
48.80
+0.59
(+1.22%)
USD |
NASDAQ |
Aug 25, 16:00
48.76
-0.04
(-0.08%)
Pre-Market: 09:10
LB Pharmaceuticals EPS Diluted (Quarterly) : -1.712 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.712 |
| March 31, 2026 | -0.6747 |
| December 31, 2025 | -0.4534 |
| September 30, 2025 | -0.1406 |
| June 30, 2025 | -0.217 |
| March 31, 2025 | -0.2097 |
| Date | Value |
|---|---|
| December 31, 2024 | -0.226 |
| September 30, 2024 | -0.6319 |
| June 30, 2024 | -1.234 |
| March 31, 2024 | -0.7198 |
| March 31, 2023 | -0.1489 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | 2.221 |
| Neumora Therapeutics, Inc. | -0.2327 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -51.60M |
| Total Expenses (Quarterly) | 51.60M |
| Enterprise Value | 1.077B |
| Earnings Yield | -6.11% |
| Normalized Earnings Yield | -6.120 |